Distribution of 235 diagnoses in the study
. | Original diagnoses, no. cases . | . | . | ||
|---|---|---|---|---|---|
| New diagnoses . | NLPHL, 111 cases . | NLPHL and T/HRBCL with unusual features, 64 cases . | T/HRBCL, 60 cases . | ||
| NLPHL, 139 cases | 108 | 31 | 0 | ||
| T/HRBCL, 79 cases | 0 | 22 | 57 | ||
| NLPHL with T-cell/histiocyte-rich nodules, 17 cases | 3 | 11 | 3 | ||
. | Original diagnoses, no. cases . | . | . | ||
|---|---|---|---|---|---|
| New diagnoses . | NLPHL, 111 cases . | NLPHL and T/HRBCL with unusual features, 64 cases . | T/HRBCL, 60 cases . | ||
| NLPHL, 139 cases | 108 | 31 | 0 | ||
| T/HRBCL, 79 cases | 0 | 22 | 57 | ||
| NLPHL with T-cell/histiocyte-rich nodules, 17 cases | 3 | 11 | 3 | ||
Columns count the number of the diagnoses at study entry. Rows give numbers of the definitive diagnoses.